XML 64 R20.htm IDEA: XBRL DOCUMENT v2.4.1.9
Common Stock (Tables)
9 Months Ended
Jan. 31, 2015
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
      Three Months Ended     Nine Months Ended  
      January 31,     January 31,  
      2015     2014     2015     2014  
  Risk-free interest rate   1.53%     1.58%     1.67%     1.61%  
  Expected volatility   54.50%     70.32%     57.50%     68.09%  
  Expected term   3.7 years     3.7 years     3.7 years     3.7 years  
  Dividend yield   0%     0%     0%     0%  
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
      Weighted Average  
      Number of     Exercise Price  
      Options     per Share  
  Outstanding at April 30, 2014   3,705,539   $ 1.62  
  Granted   871,000   $ 1.12  
  Exercised (1)   (334,731 ) $ 0.60  
  Forfeited/Cancelled   (481,225 ) $ 1.40  
  Outstanding at January 31, 2015   3,760,583   $ 1.62  
               
  Exercisable at January 31, 2015   1,916,875   $ 1.79  
  Exercisable at April 30, 2014   1,767,621   $ 1.60  
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]
      Number of     Aggregate           Number of     Aggregate  
      Options     Intrinsic           Options     Intrinsic  
  Exercise Price   Outstanding     Value     Expiry Date     Exercisable     Value  
                  August 21, 2015 to              
  $0.47   122,750   $ 31,719     September 26, 2016     122,750   $ 31,719  
  $0.78   34,000     –     December 12, 2019     –     –  
  $1.05   137,000     –     September 12, 2019     –     –  
  $1.15   700,000     –     July 11, 2019     87,500     –  
  $1.23   20,833     –     January 13, 2019     20,833     –  
  $1.31   600,000     –     December 12, 2018     162,500     –  
  $1.41   100,000     –     October 1, 2018     31,250     –  
  $1.70   650,000     –     December 14, 2016     501,042     –  
                  December 14, 2015 to              
  $1.90   845,000     –     July 25, 2018     554,375     –  
  $2.00   6,000     –     February 28, 2015     6,000     –  
  $2.15   240,000     –     September 7, 2016     240,000     –  
  $2.90   305,000     –     July 19, 2017     190,625     –  
 

January 31, 2015

  3,760,583   $ 31,719           1,916,875   $ 31,719  
   April 30, 2014   3,705,539   $ 353,637           1,767,621   $ 332,137  
Schedule of Nonvested Performance-based Units Activity [Table Text Block]
            Weighted  
      Number of     Average Grant  
      Options     Date Fair Value  
  Non-vested options at April 30, 2014   1,937,918   $ 0.87  
  Granted   871,000   $ 0.49  
  Vested   (622,293 ) $ 0.87  
  Cancelled/Forfeited   (342,917 ) $ 0.68  
  Non-vested options at January 31, 2015   1,843,708   $ 0.72  
Schedule of Employee and Non-Employee Service Share-based Compensation Allocation of Recognized Period Costs [Table Text Block]
      Three Months Ended     Nine Months Ended  
      January 31,     January 31,  
      2015     2014     2015     2014  
  Cost of sales $ 22,617   $ 18,189   $ 58,704   $ 45,027  
  Sales and marketing   86,265     72,517     212,699     269,790  
  Research and development   21,014     15,339     51,026     39,876  
  General and administrative   59,390     50,682     180,411     121,252  
  Total stock-option based compensation   189,286   $ 156,727   $ 502,840   $ 475,945  
Schedule of Stockholders' Equity Note, Warrant Liability [Table Text Block]
      January 31,     April 30,  
      2015     2014  
  Opening balance at the beginning of the period/year $   –   $ 93,057  
  Fair value of warrant liability, at issuance   –     –  
  Change in fair value of warrant liability   –     (93,057 )
  Fair value of warrants exercised during the period/year   –     –  
  Fair value of warrant liability at end of period/year $   –   $   –  
Schedule of Stockholders' Equity Note, Warrants or Rights, Valuation Assumptions [Table Text Block]
                  As at the date of  
      As at     As at     issuance  
      January 31, 2015     April 30, 2014     June 14, 2011  
  Risk-free interest rate   –     –     1.60%  
  Expected volatility   –     –     70%  
  Expected term   –     –     1.5 years to 2 years  
  Dividend yield   –     –     0%  
Schedule of Stockholders' Equity Note, Warrants or Rights, Activity [Table Text Block]
      Number of     Weighted Average        
      Warrants     Exercise Price     Expiry Dates  
 

Warrants at April 30, 2014

  732,500   $ 3.25     June 19, 2014  
  Granted   –     –     –  
  Exercised   –     –     –  
  Expired   (732,500 ) $ 3.25     –  
  Warrants at January 31, 2015   –     –     –  
Schedule of Stockholders Equity Deferred Share Unit Plan [Table Text Block]
            Weighted  
            Average Grant  
            Date Fair  
      Number of DSUs     Value Per Unit  
  DSUs outstanding at April 30, 2014   1,672,434   $ 1.09  
  Granted   326,613   $ 1.17  
  Conversions   –     –  
  DSUs outstanding at January 31, 2015   1,999,047   $ 1.10  
Schedule of Stockholders Equity Non Vested Deferred Share Units [Table Text Block]
            Weighted  
            Average Grant  
            Date Fair  
      Number of DSUs     Value Per Unit  
  Non-vested DSUs at April 30, 2014   156,778   $ 2.16  
  Granted   326,613   $ 1.17  
  Vested   (231,701 ) $ 1.52  
  Non-vested DSUs at January 31, 2015   251,690   $ 1.47  
Schedule of Allocation of Share Based Compensation Costs for Deferred Share Units [Table Text Block]
      Three Months Ended     Nine Months Ended  
      January 31,     January 31,  
      2015     2014     2015     2014  
  Sales and marketing $   –   $ 6,667   $ 1,667   $ 20,001  
  Research and development   2,082     2,082     6,246     6,246  
  General and administrative   41,974     45,507     292,709     345,834  
  Total DSU-based compensation $ 44,056   $ 54,256   $ 300,622   $ 372,081